WO1998024410A3 - Controlled release matrix tablet and method for its preparation - Google Patents
Controlled release matrix tablet and method for its preparation Download PDFInfo
- Publication number
- WO1998024410A3 WO1998024410A3 PCT/JP1997/004385 JP9704385W WO9824410A3 WO 1998024410 A3 WO1998024410 A3 WO 1998024410A3 JP 9704385 W JP9704385 W JP 9704385W WO 9824410 A3 WO9824410 A3 WO 9824410A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- controlled release
- active ingredient
- release matrix
- matrix tablet
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU51358/98A AU5135898A (en) | 1996-12-03 | 1997-12-02 | Controlled release matrix tablet and method for its preparation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8/322750 | 1996-12-03 | ||
JP32275096 | 1996-12-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998024410A2 WO1998024410A2 (en) | 1998-06-11 |
WO1998024410A3 true WO1998024410A3 (en) | 1998-08-20 |
Family
ID=18147230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1997/004385 WO1998024410A2 (en) | 1996-12-03 | 1997-12-02 | Controlled release matrix tablet and method for its preparation |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5135898A (en) |
WO (1) | WO1998024410A2 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0002574A1 (en) * | 1977-12-08 | 1979-06-27 | Beecham Group Plc | Dispersions in particulate form, a process for making the dispersions and pharmaceutical compositions containing them |
WO1984002843A1 (en) * | 1983-01-26 | 1984-08-02 | Egyt Gyogyszervegyeszeti Gyar | Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content |
FR2552665A1 (en) * | 1983-10-03 | 1985-04-05 | Rotman Avner | MICROENCAPSULE DRUG IN A SWEET MATRIX |
US4710384A (en) * | 1986-07-28 | 1987-12-01 | Avner Rotman | Sustained release tablets made from microcapsules |
EP0436373A1 (en) * | 1989-12-22 | 1991-07-10 | Syntex Pharmaceuticals International Limited | Process for making tablets containing spray-dried naproxen or naproxen sodium |
-
1997
- 1997-12-02 AU AU51358/98A patent/AU5135898A/en not_active Abandoned
- 1997-12-02 WO PCT/JP1997/004385 patent/WO1998024410A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0002574A1 (en) * | 1977-12-08 | 1979-06-27 | Beecham Group Plc | Dispersions in particulate form, a process for making the dispersions and pharmaceutical compositions containing them |
WO1984002843A1 (en) * | 1983-01-26 | 1984-08-02 | Egyt Gyogyszervegyeszeti Gyar | Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content |
FR2552665A1 (en) * | 1983-10-03 | 1985-04-05 | Rotman Avner | MICROENCAPSULE DRUG IN A SWEET MATRIX |
US4710384A (en) * | 1986-07-28 | 1987-12-01 | Avner Rotman | Sustained release tablets made from microcapsules |
EP0436373A1 (en) * | 1989-12-22 | 1991-07-10 | Syntex Pharmaceuticals International Limited | Process for making tablets containing spray-dried naproxen or naproxen sodium |
Non-Patent Citations (1)
Title |
---|
RAFIEE-TEHRANI M ET AL: "FORMULATION OF CONTROLLED RELEASE LITHIUM CARBONATE TABLETS BY FLUID BED TECHNIQUE", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, vol. 39, no. 2, 1 April 1993 (1993-04-01), pages 87 - 91, XP000363223 * |
Also Published As
Publication number | Publication date |
---|---|
AU5135898A (en) | 1998-06-29 |
WO1998024410A2 (en) | 1998-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2117351A1 (en) | Preparation of Tablets of Increased Strength | |
CA2152795A1 (en) | Readily available konjac glucomannan sustained release excipient | |
CA2196840A1 (en) | Pharmaceutical tablet suitable to deliver the active substance in subsequent and predeterminable times | |
AU3124793A (en) | Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release | |
WO2004035020A3 (en) | Controlled release preparation | |
HK1039054A1 (en) | Controlled release tablet comprising a hypoglycemic drug and an antihyperglycemic drug. | |
WO1994014421A3 (en) | Process for preparing controlled release pharmaceutical forms and the forms thus obtained | |
AU6517496A (en) | Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole | |
WO1998004249A3 (en) | Tramadol multiple unit formulations | |
CA2320900A1 (en) | Biphasic controlled release delivery system for high solubility pharmaceuticals and method | |
CA2145513A1 (en) | Pharmaceutical Tablet Capable of Liberating One or More Drugs at Different Release Rates | |
BG102228A (en) | Medicamentous form with controlled release of slightly soluble medicamentous substances | |
AU590370B2 (en) | Improvements in or relating to pharmaceutical products | |
CA2045680A1 (en) | High ibuprofen content granulations | |
AU2793989A (en) | Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained | |
WO2007132296B1 (en) | Multilayer tablet | |
AU4464897A (en) | Method for preparing a pharmaceutical composition with modified release of the active principle, comprising a matrix | |
CA2194610A1 (en) | Sustained-Release Formulation of Animal Growth Hormone and Process for Preparation Thereof | |
AU7095687A (en) | Pellet-containing pharmaceutical compositions | |
AU5139596A (en) | Pharmaceutical matrix pellets, tablets and composition for the preparation thereof | |
WO1998024410A3 (en) | Controlled release matrix tablet and method for its preparation | |
AU1515595A (en) | Method for preparing low dose pharmaceutical products | |
CA2362769A1 (en) | Microcapsules for sustained release of drugs | |
CA2007764A1 (en) | Salsalate tablet | |
CA2473718A1 (en) | Immediate-release pharmaceutical dosage form comprising polymorphous tibolone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CZ EE GE HU ID IL IS KG KR KZ LC LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK SL TJ TM TR TT UA US UZ VN YU AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CZ EE GE HU ID IL IS KG KR KZ LC LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK SL TJ TM TR TT UA US UZ VN YU AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |